BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37936209)

  • 21. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
    Dalvi S; Galloway CA; Singh R
    Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2.
    Phillips MJ; Perez ET; Martin JM; Reshel ST; Wallace KA; Capowski EE; Singh R; Wright LS; Clark EM; Barney PM; Stewart R; Dickerson SJ; Miller MJ; Percin EF; Thomson JA; Gamm DM
    Stem Cells; 2014 Jun; 32(6):1480-92. PubMed ID: 24532057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
    Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
    PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly efficient transfection of human induced pluripotent stem cells using magnetic nanoparticles.
    Yamoah MA; Moshref M; Sharma J; Chen WC; Ledford HA; Lee JH; Chavez KS; Wang W; López JE; Lieu DK; Sirish P; Zhang XD
    Int J Nanomedicine; 2018; 13():6073-6078. PubMed ID: 30323594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.
    Toivonen S; Ojala M; Hyysalo A; Ilmarinen T; Rajala K; Pekkanen-Mattila M; Äänismaa R; Lundin K; Palgi J; Weltner J; Trokovic R; Silvennoinen O; Skottman H; Narkilahti S; Aalto-Setälä K; Otonkoski T
    Stem Cells Transl Med; 2013 Feb; 2(2):83-93. PubMed ID: 23341440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells.
    Ghosh Z; Wilson KD; Wu Y; Hu S; Quertermous T; Wu JC
    PLoS One; 2010 Feb; 5(2):e8975. PubMed ID: 20126639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells.
    Xu X; Tay Y; Sim B; Yoon SI; Huang Y; Ooi J; Utami KH; Ziaei A; Ng B; Radulescu C; Low D; Ng AYJ; Loh M; Venkatesh B; Ginhoux F; Augustine GJ; Pouladi MA
    Stem Cell Reports; 2017 Mar; 8(3):619-633. PubMed ID: 28238795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells.
    Simara P; Tesarova L; Rehakova D; Farkas S; Salingova B; Kutalkova K; Vavreckova E; Matula P; Matula P; Veverkova L; Koutna I
    Stem Cells Dev; 2018 Jan; 27(1):10-22. PubMed ID: 29117787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells.
    Rouhani FJ; Zou X; Danecek P; Badja C; Amarante TD; Koh G; Wu Q; Memari Y; Durbin R; Martincorena I; Bassett AR; Gaffney D; Nik-Zainal S
    Nat Genet; 2022 Sep; 54(9):1406-1416. PubMed ID: 35953586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Joint regulation of Wnt and bone morphogenetic protein signaling pathways to promote differentiation of human induced pluripotent stem cells into cardiomyocytes].
    Yan Y; Liu F; Hou X; Wan J; Xiong Q; Zhou R; Liao B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Oct; 34(10):1313-1321. PubMed ID: 33063499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells.
    Valamehr B; Robinson M; Abujarour R; Rezner B; Vranceanu F; Le T; Medcalf A; Lee TT; Fitch M; Robbins D; Flynn P
    Stem Cell Reports; 2014 Mar; 2(3):366-81. PubMed ID: 24672758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.
    Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y
    Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.
    Wang Y; Chou BK; Dowey S; He C; Gerecht S; Cheng L
    Stem Cell Res; 2013 Nov; 11(3):1103-16. PubMed ID: 23973800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
    Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
    Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of human induced pluripotent stem cell line (BCRTi006-A) from a patient with focal segmental glomerulosclerosis disease.
    Batool L; Raab C; Beez CM; Hariharan K; Kurtz A; Gollasch M; Rossbach B
    Stem Cell Res; 2023 Jun; 69():103070. PubMed ID: 36958215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.
    Okur FV; Cevher İ; Özdemir C; Kocaefe Ç; Çetinkaya DU
    Stem Cell Res Ther; 2019 Jul; 10(1):211. PubMed ID: 31315669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
    Tesarova L; Simara P; Stejskal S; Koutna I
    PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Effects of Extracellular Vesicles of Lineage-Specific Human Pluripotent Stem Cells on the Cellular Behaviors of Isogenic Cortical Spheroids.
    Marzano M; Bejoy J; Cheerathodi MR; Sun L; York SB; Zhao J; Kanekiyo T; Bu G; Meckes DG; Li Y
    Cells; 2019 Aug; 8(9):. PubMed ID: 31466320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells.
    Fukusumi H; Shofuda T; Kanematsu D; Yamamoto A; Suemizu H; Nakamura M; Yamasaki M; Ohgushi M; Sasai Y; Kanemura Y
    PLoS One; 2013; 8(1):e55226. PubMed ID: 23383118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.